跳至主要内容
临床试验/CTRI/2009/091/000994
CTRI/2009/091/000994已完成4 期

Efficacy and safety of Ferrous Ascorbate and Colloidal Iron in pediatric patients with iron deficiency anemia.

Zuventus Healthcare Ltd0 个研究点目标入组 72 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • Children between the age group of 6 months to 12 years.
  • - Children having iron deficiency anemia with hemoglobin less than 10 gm%.
  • - Patients who would be coming for follow up after every 4 weeks for the complete study period of 12 weeks.
  • - Informed written consent given by parents/guardians of the patients.

排除标准

  • - Anemia due to other causes than iron deficiency anemia
  • - Severe concurrent illness (cardiovascular, renal, hepatic).
  • - Known hypersensitivity to Ferrous ascorbate or any other iron preparations
  • - Malignancy of any type.
  • ?Children with thalassemia major / aplastic or hypoplastic anaemia, sickle cell anaemia, any other abnormal haemoglobinopathy or any other haemolytic anaemia.
  • - Any other condition that in the opinion of the investigator does not justify the patient's inclusion.

研究者

相似试验